206 related articles for article (PubMed ID: 35820883)
1. Metformin attenuates the production and proliferative effects of prolactin induced by medroxyprogesterone acetate during fertility-sparing treatment for endometrial cancer.
Gu W; Mitsuhashi A; Kobayashi T; Shozu M
BMC Cancer; 2022 Jul; 22(1):753. PubMed ID: 35820883
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.
Mitsuhashi A; Sato Y; Kiyokawa T; Koshizaka M; Hanaoka H; Shozu M
Ann Oncol; 2016 Feb; 27(2):262-6. PubMed ID: 26578736
[TBL] [Abstract][Full Text] [Related]
3. Effect of progestin, antiprogestin, and relaxin on the accumulation of prolactin and insulin-like growth factor-binding protein-1 messenger ribonucleic acid in human endometrial stromal cells.
Tseng L; Gao JG; Chen R; Zhu HH; Mazella J; Powell DR
Biol Reprod; 1992 Sep; 47(3):441-50. PubMed ID: 1380842
[TBL] [Abstract][Full Text] [Related]
4. Progestin, estrogen, and insulin-like growth factor-I stimulate the prolactin receptor mRNA in human endometrial stromal cells.
Tseng L; Zhu HH
J Soc Gynecol Investig; 1998; 5(3):149-55. PubMed ID: 9614645
[TBL] [Abstract][Full Text] [Related]
5. Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial).
Mitsuhashi A; Kawasaki Y; Hori M; Fujiwara T; Hanaoka H; Shozu M
BMJ Open; 2020 Feb; 10(2):e035416. PubMed ID: 32114477
[TBL] [Abstract][Full Text] [Related]
6. New therapeutic approaches for the fertility-sparing treatment of endometrial cancer.
Mitsuhashi A; Shozu M
J Obstet Gynaecol Res; 2020 Feb; 46(2):215-222. PubMed ID: 32017321
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients.
Mitsuhashi A; Habu Y; Kobayashi T; Kawarai Y; Ishikawa H; Usui H; Shozu M
J Gynecol Oncol; 2019 Nov; 30(6):e90. PubMed ID: 31576686
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein-1 induces decidualization of human endometrial stromal cells via alpha5beta1 integrin.
Matsumoto H; Sakai K; Iwashita M
Mol Hum Reprod; 2008 Aug; 14(8):485-9. PubMed ID: 18583428
[TBL] [Abstract][Full Text] [Related]
9. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
Niu YJ; Shi HR; Xie Y
Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
[TBL] [Abstract][Full Text] [Related]
10. Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview.
Gullo G; Etrusco A; Cucinella G; Perino A; Chiantera V; Laganà AS; Tomaiuolo R; Vitagliano A; Giampaolino P; Noventa M; Andrisani A; Buzzaccarini G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769256
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of progestin and RU 486 on prolactin production and synthesis in human endometrial stromal cells.
Chen G; Huang JR; Mazella J; Tseng L
Hum Reprod; 1989 May; 4(4):355-8. PubMed ID: 2526151
[TBL] [Abstract][Full Text] [Related]
12. Regulation of prolactin production by progestin, estrogen, and relaxin in human endometrial stromal cells.
Huang JR; Tseng L; Bischof P; Jänne OA
Endocrinology; 1987 Dec; 121(6):2011-7. PubMed ID: 2960516
[TBL] [Abstract][Full Text] [Related]
13. NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB.
Cheng Y; Xie L; Xu Z; Hao M; Yang B; Shan W; Wang Y; Lv Q; Chen X
Cancer Gene Ther; 2022 Oct; 29(10):1452-1462. PubMed ID: 35388173
[TBL] [Abstract][Full Text] [Related]
14. MET Inhibits the Proliferation of EC Cells by Increasing MPA Sensitivity.
Sun F; Zhou J; Hao Y; Kuang L; Zhang B
Altern Ther Health Med; 2023 Jul; 29(5):334-341. PubMed ID: 37171945
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
Zhao S; Chen X; Lu X; Yu Y; Feng Y
Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
[TBL] [Abstract][Full Text] [Related]
16. RNA-seq and ATAC-seq analysis of CD163
Wang L; Lv Q; Wu P; Luo S; Liu S; Chen X; Luo X
Cancer Med; 2023 Mar; 12(5):5964-5978. PubMed ID: 36373483
[TBL] [Abstract][Full Text] [Related]
17. Laminin decreases PRL and IGFBP-1 expression during in vitro decidualization of human endometrial stromal cells.
Brar AK; Frank GR; Richards RG; Meyer AJ; Kessler CA; Cedars MI; Klein DJ; Handwerger S
J Cell Physiol; 1995 Apr; 163(1):30-7. PubMed ID: 7534770
[TBL] [Abstract][Full Text] [Related]
18. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression.
Schatz F; Papp C; Aigner S; Krikun G; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):188-93. PubMed ID: 8989257
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of progestin and relaxin on the synthesis and secretion of immunoreactive prolactin in long term culture of human endometrial stromal cells.
Zhu HH; Huang JR; Mazella J; Rosenberg M; Tseng L
J Clin Endocrinol Metab; 1990 Oct; 71(4):889-99. PubMed ID: 2144857
[TBL] [Abstract][Full Text] [Related]
20. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
Ushijima K; Yahata H; Yoshikawa H; Konishi I; Yasugi T; Saito T; Nakanishi T; Sasaki H; Saji F; Iwasaka T; Hatae M; Kodama S; Saito T; Terakawa N; Yaegashi N; Hiura M; Sakamoto A; Tsuda H; Fukunaga M; Kamura T
J Clin Oncol; 2007 Jul; 25(19):2798-803. PubMed ID: 17602085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
